Arrowhead Pharmaceuticals (STU:HDP1) Construction In Progress : €145.58 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Arrowhead Pharmaceuticals Construction In Progress?

Arrowhead Pharmaceuticals's quarterly construction in progress declined from Sep. 2023 (€156.16 Mil) to Dec. 2023 (€125.55 Mil) but then increased from Dec. 2023 (€125.55 Mil) to Mar. 2024 (€145.58 Mil).

Arrowhead Pharmaceuticals's annual construction in progress increased from Sep. 2021 (€0.29 Mil) to Sep. 2022 (€56.94 Mil) and increased from Sep. 2022 (€56.94 Mil) to Sep. 2023 (€156.16 Mil).

Arrowhead Pharmaceuticals Construction In Progress Historical Data

The historical data trend for Arrowhead Pharmaceuticals's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arrowhead Pharmaceuticals Construction In Progress Chart

Arrowhead Pharmaceuticals Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Construction In Progress

Get a 7-Day Free Trial

0.29

56.94

156.16

Arrowhead Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															118.82	109.17	156.16	125.55	145.58

Arrowhead Pharmaceuticals Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Arrowhead Pharmaceuticals (STU:HDP1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arrowhead Pharmaceuticals Inc (STU:HDP1) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

ARWR:USA

Address

177 E. Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105

Website

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Arrowhead Pharmaceuticals (STU:HDP1) Headlines

No Headlines